Literature DB >> 24833534

Lectin-based estimation of glycated hemoglobin in diabetes mellitus.

Pranab S Basu1, Sudip Chatterji, Sandip K Batabyal.   

Abstract

This study was undertaken to distinguish between normal and diabetic subjects by lectin-glycated hemoglobin interaction. The quantitative precipitin method was performed for the interaction between glucose-specific lectin Concanavalin A (Con A) and the glucose-containing RBC-lysate for the estimation of calculated HbA1c% from a standard curve. The standard curve was prepared by plotting the optical density of the precipitin for the interaction of standard HbA1c concentration with Con A against HbA1c reference standard. The absorbance range of the precipitate was 0.14-0.20 in normal subjects and the corresponding calculated HbA1c% along with plasma glucose (mg/dl) levels was 4.1-5.8% and 82-101 mg/dl respectively. Higher absorbance values, 0.22-0.42, were obtained in diabetic patients when the calculated HbA1c% was 6.3-12.2% and plasma glucose level was 120-292 mg/dl. Almost similar results were observed for HbA1c% (6.1-11.9%) of the same diabetic samples measured by conventional ion-exchange high performance liquid chromatography (HPLC). Excellent correlation coefficients of the two methods from regression analysis graph for normal (r = 0.98) and diabetic patients (r = 0.99) were observed. Furthermore, nondiabetic and diabetic hemoglobin variant subjects showed similar HbA1c% by our lectin-based assay when compared with standard HPLC method. We conclude that this lectin-based assay may be adopted to estimate glycated hemoglobin level in differentiating between normal and diabetic patients. This assay offers a good correlation with standard HPLC method. Moreover; the method is convenient, cheap, and needs no sophisticated instruments.
© 2012 Wiley Periodicals, Inc.

Entities:  

Keywords:  concanavalin A; diabetes; glycated hemoglobin; hemoglobin variants; lectin

Mesh:

Substances:

Year:  2012        PMID: 24833534      PMCID: PMC6807417          DOI: 10.1002/jcla.20503

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  10 in total

1.  Effects of nine hemoglobin variants on five glycohemoglobin methods.

Authors:  W L Roberts; E L Frank; L Moulton; C Papadea; J K Noffsinger; C N Ou
Journal:  Clin Chem       Date:  2000-04       Impact factor: 8.327

2.  Standards of medical care in diabetes--2007.

Authors: 
Journal:  Diabetes Care       Date:  2007-01       Impact factor: 19.112

3.  Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus.

Authors: 
Journal:  Diabetes Care       Date:  1997-07       Impact factor: 19.112

4.  Interlaboratory standardization of glycated hemoglobin determinations.

Authors:  R R Little; J D England; H M Wiedmeyer; E M McKenzie; R Mitra; P M Erhart; J B Durham; D E Goldstein
Journal:  Clin Chem       Date:  1986-02       Impact factor: 8.327

5.  Protein-carbohydrate interaction. IV. Application of the quantitative precipitin method to polysaccharide-concanavalin A interaction.

Authors:  L L So; I J Goldstein
Journal:  J Biol Chem       Date:  1967-04-10       Impact factor: 5.157

6.  Lectin and serum-PSA interaction as a screening test for prostate cancer.

Authors:  Pranab S Basu; Ramdhan Majhi; Sandip K Batabyal
Journal:  Clin Biochem       Date:  2003-07       Impact factor: 3.281

7.  The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.

Authors:  D M Nathan; S Genuth; J Lachin; P Cleary; O Crofford; M Davis; L Rand; C Siebert
Journal:  N Engl J Med       Date:  1993-09-30       Impact factor: 91.245

8.  Medical management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes.

Authors:  D M Nathan; J B Buse; M B Davidson; E Ferrannini; R R Holman; R Sherwin; B Zinman
Journal:  Diabetologia       Date:  2008-10-22       Impact factor: 10.122

9.  Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.

Authors: 
Journal:  Lancet       Date:  1998-09-12       Impact factor: 79.321

10.  Clinical utility of the interaction between lectin and serum prostate specific antigen in prostate cancer.

Authors:  S K Batabyal; R Majhi; P S Basu
Journal:  Neoplasma       Date:  2009       Impact factor: 2.575

  10 in total
  1 in total

Review 1.  Recent Progress in Electrochemical HbA1c Sensors: A Review.

Authors:  Baozhen Wang; Jun-Ichi Anzai
Journal:  Materials (Basel)       Date:  2015-03-17       Impact factor: 3.623

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.